Concepedia

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

David Michelson, Ellen Snyder, Erin M. Paradis, Mary Chengan-Liu, Duane Snavely, Jill Hutzelmann, James K. Walsh, Andrew D. Krystal, Ruth M. Benca, Martin A. Cohn,

The Lancet Neurology · 2014 · 509 citations · 18 references

DOI

Concepts

References

18

ECDEU Assessment Manual for Psychopharmacology

William Guy · Bulletin of Miscellaneous Information (Royal Gardens Kew) · 1976 · 8.8K citations

, , +7

Validation of the Insomnia Severity Index as an outcome measure for insomnia research

Célyne Bastien · Sleep Medicine · 2001 · 8K citations

, , +15

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

Kelly Posner, Gregory K. Brown, Bárbara Stanley et al. · American Journal of Psychiatry · 2011 · 5K citations

, , +15

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

A. John Rush, Madhukar H. Trivedi, Hicham M. Ibrahim et al. · Biological Psychiatry · 2003 · 3.9K citations

, , +17

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

Christelle Peyron, Juliette Faraco, William M. Rogers et al. · Nature Medicine · 2000 · 2.1K citations

, , +13